Skip directly to: Navigation for this section | Main page content

Post Graduate Researchers

Bruce D. Hammock Laboratory


Name

Research Project

Katrin Georgi

Metabolomics (i.e. Metabolomic study of ozone and 1-nitronaphthalene toxicity); Oxylipin analysis; Development of analytical methods for LC-MS/MS and GC (i.e. endocannabinoids; lipid amides).

Todd Harris

Characterization of soluble epoxide hydrolases from non-mammalian species. Isolation, purification and enzyme inhibition.

Christine Hegedus

Ozone exposure, in silico model validation of in vitro data, sEH interaction with NFkB, sEHI in pain and inflammation.

Sung Hee Hwang

Development of COX-2/sEH dual inhibitors as safe anti-inflammatiory drugs.  Discovery of compounds that can inhibit both COX-2 and sEH enzymes using modern medicinal approach.

Ahmet 'Bora' Inceoglu

Assessment of the role of sEH in nervous system. Investigate the effects of inhibiting sEH in animal models of pain.

Hee Joo Kim

Development of immunoassays for pyrethroid metabolites.  Development of novel immunoassay formats using phage peptide display.

Junyan Liu

Evaluation of sEH inhibitors’ efficacy in animal models.  Exploration of the crosstalk between P450 (sEH) and other pathways (COX & LOX).  Investigation of the role of sEH in the development, prevention, and treatment of COPD using metabolomics methods.

Mikaela Nichkova

Application of immunoassays for contaminants and their metabolites to environmental and biological samples. Development of new detection formats (biosensors, arrays, cell labeling) based on fluorescent and/or magnetic immunoassays using nanoparticles (QDots, europium oxide, etc.) as labels. Detection of food-borne toxins (e.g. BoTox) and plant toxins (e.g. ricin) in food samples with multifunctional nanoparticles.

Jun Yang

Metabolomics, LC/MS and GC/MS methods development, chemometrics.

Angela Zivkovic

Eicosanoid biology and nutritional modulation of inflammation, with a focus on omega-3 fatty acids.  How omega-3 fatty acids modulate lipid signaling in various inflammatory disease states, including metabolic disease and kidney disease.